Benefits of Our Test Method vs HPLC and GC

Comparing a laboratory’s test method with high-performance liquid chromatography (HPLC) and gas chromatography (GC) requires more than naming an instrument. HPLC and GC are analytical separation techniques; a defensible comparison depends on the target compounds, sample matrix, preparation procedure, detector, calibration, validation, and the question the test is intended to answer. No method is automatically superior for every cannabinoid or sample.

This page explains the main differences relevant to cannabinoid analysis and outlines what professional buyers should verify before relying on a certificate of analysis (COA) or a claim that one method performs better. For general background, see our cannabinoid research overview and guide to cannabinoids.

What HPLC and GC measure

Both methods separate components in a prepared sample so they can be detected and measured. In HPLC, the sample travels in a liquid mobile phase through a chromatographic column. In GC, volatile compounds travel through a column with a carrier gas, while the instrument controls the column temperature. The detector and method settings determine what signals are produced and how those signals are interpreted.

For cannabinoid work, the distinction matters because some cannabinoids occur in acidic and neutral forms. A method should state whether it reports these forms separately, reports a calculated total, or measures a result after a preparation step that changes the sample. The reported value is therefore tied to the method definition, not just the instrument name.

HPLC: direct analysis of acidic and neutral forms

HPLC methods can analyze acidic and neutral cannabinoids without first relying on heat in a GC injection port to convert acidic forms. Depending on the validated method and detector, the laboratory may quantify compounds such as THCA and THC as distinct analytes, then report them separately or calculate a defined total. This can be useful when the original profile of a sample is important.

HPLC results still depend on adequate extraction, sample homogenization, chromatographic separation, reference standards, calibration, matrix suitability, and quality controls. Co-elution, poor recovery, inappropriate dilution, or an unsuitable calibration range can affect results. HPLC is not inherently accurate simply because it is liquid chromatography: the complete procedure must be validated or verified for the intended sample and analytes.

GC: useful separation with temperature-related considerations

GC can provide effective analysis of suitable volatile or derivatized compounds and is widely used with detectors such as flame ionization detection (FID) or mass spectrometry (MS). However, the heated inlet and oven conditions can affect cannabinoid acids. Without a suitable derivatization or other validated approach, acidic cannabinoids may decarboxylate during analysis, and conversion may be incomplete; heat-sensitive analytes may also be affected.

Consequently, a GC report must make clear whether the method includes derivatization, controlled decarboxylation, or another defined preparation, and how the reported values should be interpreted. A recent study comparing approaches for cannabinoid oils reported that GC-MS without derivatization could underestimate total THC and CBD in the tested samples, illustrating why method-specific validation matters. This finding is specific to the study conditions, not a universal verdict on all GC methods. See the PubMed study on GC-MS decarboxylation and cannabinoid quantification.

HPLC vs GC: choose for the analytical question

• Acidic and neutral cannabinoid profiling: Review whether the method measures each form directly or uses a defined conversion step, and whether the report gives separate and total values.
• Volatile analytes or a GC-specific application: Confirm that sample preparation, derivatization where needed, and instrument conditions are validated for the compounds being reported.
• Complex or finished-product matrices: Check that extraction and recovery were assessed in a representative matrix, not assumed from a different sample type.
• Regulatory or specification decisions: Confirm the method and reporting format meet the requirements applicable to the destination market and product category.

Authoritative method guidance reinforces that the full procedure must be fit for purpose. The UNODC recommended methods for cannabis analysis discusses GC-related decarboxylation considerations and the need for appropriate method validation. The details of a laboratory’s method and its validation remain essential when interpreting an individual result.

What a meaningful method comparison should include

A substantiated comparison should identify the exact method version and analytes; sample type and preparation; detector and relevant operating conditions; calibration model and reference materials; selectivity and resolution; accuracy or recovery; precision; working range; limit of detection and limit of quantification; and applicable quality-control checks. It should also explain any calculations, conversion factors, and uncertainty relevant to the reported result.

For buyers reviewing a COA, verify that the sample and batch identifiers match the material received, the units and basis are clear, and the tested analytes align with the specification. Ask whether the laboratory is competent for that method and matrix, whether proficiency testing or other quality controls apply, and whether the COA is a complete report rather than a marketing summary. Our third-party laboratory testing information provides related context.

Limits and responsible interpretation

A chromatographic result describes the analytes covered by the method in the sample tested. It does not, by itself, establish the safety, legal status, performance, or suitability of a finished product. Sampling representativeness, sample handling, matrix effects, reference standards, instrument condition, analyst practice, and data review can all influence the final report.

Claims that an in-house or alternative test method is “better” than HPLC or GC should therefore be supported by documented, comparative validation using relevant samples and predefined performance criteria. Without that evidence, the appropriate conclusion is limited: the method may be suitable for a specified purpose if its performance has been demonstrated for that purpose.

FAQ: cannabinoid testing methods

Is HPLC always better than GC for cannabinoids?

No. The appropriate method depends on the analytes, sample matrix, preparation, reporting goal, and validated performance. HPLC can measure acidic and neutral forms directly in suitable methods; GC can be appropriate when its thermal and preparation effects are controlled and documented.

Can GC results be compared directly with HPLC results?

Not without checking what each method measures and reports. Preparation, conversion of acidic forms, calibration, detector response, sample basis, and calculation rules can differ. A comparison should use equivalent analytes, units, samples, and validated procedures.

What should a buyer request from a laboratory?

Request the method identity and scope, sample and batch traceability, analytes and units, relevant validation or verification information, quality-control details, and a complete COA. The documentation should answer the intended quality question rather than rely on an instrument label alone.

Conclusion

The benefits of a test method versus HPLC and GC cannot be established by a broad superiority claim. A fair comparison explains the analytical question, the full sample-to-result procedure, method validation, and limitations. HPLC and GC each have useful applications, but cannabinoid results must be interpreted in light of how acidic and neutral forms, sample preparation, and instrument conditions are handled. For procurement and quality decisions, evaluate the documented method and batch-specific evidence—not the platform name alone.